On Thursday, two separate pieces of news dropped about Anthropic within hours of each other, and together they tell a more interesting story than either does on its own. Bloomberg reported that the company is weighing an IPO as soon as October, potentially valuing it above $60 billion. At almost the same moment, a federal judge in San Francisco issued a preliminary injunction blocking the Trump administration's attempt to bar federal agencies from using Anthropic's technology. A company that was facing the threat of being cut off from a major revenue stream in the morning was contemplating stock market listings in the afternoon.
The court case is worth understanding clearly. The Pentagon designated Anthropic a "supply chain risk" after the company refused to allow its models to be used for mass surveillance of Americans or for autonomous weapons decisions. The administration then sought to sever all federal government contracts. US District Judge Rita F. Lin paused that action, agreeing that Anthropic had shown enough likelihood of prevailing on the merits to justify keeping the existing relationships intact while the full case plays out. The injunction does not resolve the underlying dispute; it just prevents the government from inflicting the damage first and arguing later.
What makes the pairing with the IPO news striking is the question it raises about Anthropic's strategic calculus. Going public at a $60 billion-plus valuation while simultaneously fighting a White House ban on government contracts is an unusual position. Public market investors will need to price the legal and political risk alongside the obvious commercial momentum. Claude's user numbers, the expanding enterprise business, and the recent announcement of computer-use capabilities all point upward. The DOD lawsuit points in a less comfortable direction.
There is also a deeper tension in Anthropic's position that the IPO conversation makes harder to ignore. The company was founded explicitly on the premise that AI safety should not be subordinated to commercial pressure. That premise is genuinely difficult to maintain as a publicly traded company subject to quarterly earnings pressure and shareholder primacy. The comparison with OpenAI's ongoing restructuring from capped-profit to fully commercial is unavoidable. Both companies appear to be converging on the same practical reality despite starting from different stated positions.
What Anthropic's IPO timeline actually signals is that the safety-versus-commercialisation tension is no longer a theoretical problem for the next decade. It is arriving on a schedule that lawyers and investment bankers are already working around. The October window is tight, and how the DOD case resolves before then could significantly affect the pricing. For now, Anthropic finds itself in the odd position of being simultaneously too principled for the Pentagon and ambitious enough to court Wall Street.